Effect of Alprostadil Combined with Mosapride on Diabetic Gastroparesis Patients

郑海龙,王海凤,王转锁,宋钦华
DOI: https://doi.org/10.13604/j.cnki.46-1064/r.2012.08.043
2012-01-01
Abstract:Objective To observe the therapeutic outcome of alprostadil combined with mosapride on diabetic gastroparesis patients.Methods A total of 60 patients with diabetic gastroparesis were randomly divided into treatment group(n=30)treated with mosapride in combination with alprostadil and control group(n=30)only treated with mosapride for a course of 4 weeks.clinical symptoms and gastroscopy were observed before treatment and 4 weeks after treatment.Results The total effective rate was 93.3%(28/30)higher significantly in the treatment group Compared with the control group(73.3%)(P0.05).No obvious side effects were observed.Conclusion The clinical efficacy of alprostadil combined with mosapride is effective and safe for treatment of diabetic gastroparesis patients.
What problem does this paper attempt to address?